Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLIDARITY PLUS Finland Long-COVID
NCT05220280Phase 4Recruiting
- Sponsor
- Clinical Urology and Epidemiology Working Group
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of imatinib, infliximab in coronavirus disease 2019 (COVID-19), sponsored by Clinical Urology and Epidemiology Working Group. Started Feb 2022; status: recruiting.
02
Drugs
imatinibinfliximab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05220280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05220280.